Drawing for INHALE DELIVERS

USPTO serial 75580984

INHALE DELIVERS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WARD, JOYCE A.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INHALE DELIVERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Schwab

BRUCE W SCHWAB TOWNSEND AND TOWNSEND AND CREW LLPTWO EMBARCADERO CTR 8TH FLSAN FRANCISCO, CA 94111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OF THE PERIPHERAL NERVE, OF THE ADRENERGIC AND CHOLINERGIC RECEPTORS; OF THE SKELETAL AND SMOOTH MUSCLE SYSTEMS, CARDIOVASCULAR SYSTEMS, ENDOCRINE AND HORMONE SYSTEMS, BLOOD CIRCULATORY AND IMMUNOLOGICAL SYSTEMS, OF THE SYNOPTIC AND NEUROEFFECTOR JUNCTIONAL SITES, OF THE REPRODUCTIVE, SKELETAL AND AUTACOID SYSTEMS, THE ALIMENTARY AND EXCRETORY SYSTEMS, AND THE HISTAMINE AND CENTRAL NERVOUS SYSTEMS, IN THE NATURE OF DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE DRY PARTICLES TO THE DEEP LUNG, OTHERWISE REQUIRING OTHER DRUG DELIVERY MEANS FOR TREATMENTACTIVE—
040CUSTOM ADAPTATION, ALTERATION, AND REFORMULATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM AS FINE, DRY PARTICLESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 10, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 10, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 31, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 18, 2001NPUBNOTICE OF PUBLICATION—
Feb 23, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 16, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 20, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 14, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 1999DOCKASSIGNED TO EXAMINER—
May 24, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance